What Happened
The shares of Symbiotec Pharmalab IPO are commanding a strong premium of ₹270 in the grey market. The GMP of Symbiotec Pharmalab IPO is +270, according to Investorgain.
In one line — The shares of Symbiotec Pharmalab IPO are commanding a strong premium of ₹270 in the grey market. The GMP of Symbiotec Pharmalab IPO is +270, according to Investorgain.
Source: Mint · AI-summarised by Anadi · Updated 28 Aug 2026, 1:15 PM IST
The shares of Symbiotec Pharmalab IPO are commanding a strong premium of ₹270 in the grey market. The GMP of Symbiotec Pharmalab IPO is +270, according to Investorgain.